Alterations of plasma and cerebrospinal fluid glutamate levels in rats treated with the N-methyl-D-aspartate receptor antagonist, ketamine.

Source:http://linkedlifedata.com/resource/pubmed/id/16779778

Download in:

View as

General Info

PMID
16779778